These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28150186)

  • 41. Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.
    Gimpelewicz C; Metra M; Cleland JGF; Szecsödy P; Chang Wun CC; Boer-Martins L; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Pang P; Ponikowski P; Severin T; Voors AA; Teerlink JR
    Am Heart J; 2017 Aug; 190():113-122. PubMed ID: 28760204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relaxin' the Heart: A Novel Therapeutic Modality.
    Raleigh JM; Toldo S; Das A; Abbate A; Salloum FN
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):353-62. PubMed ID: 26589290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure.
    Ponikowski P; Mitrovic V; Ruda M; Fernandez A; Voors AA; Vishnevsky A; Cotter G; Milo O; Laessing U; Zhang Y; Dahlke M; Zymlinski R; Metra M
    Eur Heart J; 2014 Feb; 35(7):431-41. PubMed ID: 24255129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and tolerability of serelaxin, a recombinant human relaxin-2 in development for the treatment of acute heart failure, in healthy Japanese volunteers and a comparison of pharmacokinetics and pharmacodynamics in healthy Japanese and Caucasian populations.
    Dahlke M; Ng D; Yamaguchi M; Machineni S; Berger S; Canadi J; Rajman I; Lloyd P; Pang Y
    J Clin Pharmacol; 2015 Apr; 55(4):415-22. PubMed ID: 25408331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study.
    Felker GM; Mentz RJ; Teerlink JR; Voors AA; Pang PS; Ponikowski P; Greenberg BH; Filippatos G; Davison BA; Cotter G; Prescott MF; Hua TA; Lopez-Pintado S; Severin T; Metra M
    Eur J Heart Fail; 2015 Dec; 17(12):1262-70. PubMed ID: 26333655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.
    Oluleye OW; Rector TS; Win S; McMurray JJ; Zile MR; Komajda M; McKelvie RS; Massie B; Carson PE; Anand IS
    Circ Heart Fail; 2014 Nov; 7(6):960-6. PubMed ID: 25225241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging role of serelaxin in the therapeutic armamentarium for heart failure.
    Varr BC; Maurer MS
    Curr Atheroscler Rep; 2014 Oct; 16(10):447. PubMed ID: 25108571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Top heart-failure contender serelaxin flops.
    Nat Biotechnol; 2017 Apr; 35(4):297. PubMed ID: 28398333
    [No Abstract]   [Full Text] [Related]  

  • 49. Serelaxin, recombinant human relaxin-2, for heart failure patients: A systematic review and meta-analysis.
    Yu L; Cao L; Sun J; Li Z; Yao F; Zhou Y
    Medicine (Baltimore); 2018 Jun; 97(25):e11010. PubMed ID: 29923986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood Pressure Drops During Hospitalization for Acute Heart Failure Treated With Serelaxin: A Patient-Level Analysis of 4 Randomized Controlled Trials.
    Grand J; Miger K; Sajadieh A; Køber L; Torp-Pedersen C; Ertl G; López-Sendón J; Pietro Maggioni A; Teerlink JR; Sato N; Gimpelewicz C; Metra M; Holbro T; Nielsen OW
    Circ Heart Fail; 2022 Apr; 15(4):e009199. PubMed ID: 35184572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of serelaxin in patients with severe renal impairment or end-stage renal disease requiring hemodialysis: A single-dose, open-label, parallel-group study.
    Dahlke M; Halabi A; Canadi J; Tsubouchi C; Machineni S; Pang Y
    J Clin Pharmacol; 2016 Apr; 56(4):474-83. PubMed ID: 26239266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond.
    Cotter G; Milo O; Davison BA
    Curr Heart Fail Rep; 2014 Mar; 11(1):19-30. PubMed ID: 24363020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetics of serelaxin in patients with acute or chronic heart failure, hepatic or renal impairment, or portal hypertension and in healthy subjects.
    Soubret A; Pang Y; Yu J; Dahlke M
    Br J Clin Pharmacol; 2018 Nov; 84(11):2572-2585. PubMed ID: 30014598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal hemodynamic effects of serelaxin in patients with chronic heart failure: a randomized, placebo-controlled study.
    Voors AA; Dahlke M; Meyer S; Stepinska J; Gottlieb SS; Jones A; Zhang Y; Laurent D; Slart RH; Navis GJ
    Circ Heart Fail; 2014 Nov; 7(6):994-1002. PubMed ID: 25286914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic burden and co-morbidities of atrial fibrillation in a privately insured population.
    Wu EQ; Birnbaum HG; Mareva M; Tuttle E; Castor AR; Jackman W; Ruskin J
    Curr Med Res Opin; 2005 Oct; 21(10):1693-9. PubMed ID: 16238910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant human relaxin versus placebo for cervical ripening: a double-blind randomised trial in pregnant women scheduled for induction of labour.
    Weiss G; Teichman S; Stewart D; Nader D; Wood S; Breining P; Unemori E
    BMC Pregnancy Childbirth; 2016 Sep; 16(1):260. PubMed ID: 27596360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serelaxin: new investigational treatment in acute heart failure.
    Said S; Mukherjee D
    Cardiovasc Hematol Agents Med Chem; 2013 Sep; 11(3):243-8. PubMed ID: 24289727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome in the real world: Data from the Berlin AFibACS Registry.
    Maier B; Hegenbarth C; Theres H; Schoeller R; Schuehlen H; Behrens S;
    Cardiol J; 2014; 21(5):465-73. PubMed ID: 24142683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation.
    Flint AC; Conell C; Ren X; Kamel H; Chan SL; Rao VA; Johnston SC
    Stroke; 2017 Jul; 48(7):1788-1794. PubMed ID: 28596457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.
    Teerlink JR; Metra M; Felker GM; Ponikowski P; Voors AA; Weatherley BD; Marmor A; Katz A; Grzybowski J; Unemori E; Teichman SL; Cotter G
    Lancet; 2009 Apr; 373(9673):1429-39. PubMed ID: 19329178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.